Cooper Pharma Limited, a active public limited company, was established on 02 February 1989 in Delhi, Delhi, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24231DL1989PLC034902. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹3.00 Cr and a paid-up capital of ₹1.00 Cr.
Formerly known as Cooper Pharma Private Limited. It upholds a compliant status. Employing 122 professional, Its leadership includes Rakesh Bhargava (Managing Director), Dinesh Kumar (Director), Abhishek Bhargava (Whole-Time Director). Past directors included Rakesh Bhargava, Lata Bhargava, Abhijit Sengupta. It holds ₹3.03 Cr open charges and ₹22.60 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No. - 5, Nidhi Plaza - Ii, 2Nd Floor,, L.S.C. Gulabi Bagh, Delhi, Delhi, 110052.
U24231DL1989PLC034902
034902
02 February 1989
₹3.00 Cr
₹1.00 Cr
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Cooper Pharma Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rakesh Bhargava | Managing Director | 02 Feb 1989 | Current |
| Dinesh Kumar | Director | 05 Jun 2024 | Current |
| Abhishek Bhargava | Whole-Time Director | 01 Aug 2009 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 30 Oct 2009 | Past |
| Pramod Abcsdd | Director | 24 Dec 2013 | Past |
| Pramod Abcsdd | Director | 21 May 2019 | Past |
| Pramod Abcsdd | Additional Director | 29 Oct 2020 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2024 | Past |
| Pramod Abcsdd | Director | 30 Sep 2011 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Cooper Pharma Limited, for the financial year ended 2024, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
In 2024, Cooper Pharma had a promoter holding of 99.81% and a public holding of 0.19%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹30,250,000.00
₹225,990,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Apr 2011 | Punjab National Bank | ₹0.25 M | Open |
| 28 Mar 2006 | Small Industries Developmnt Bank Of India | ₹3.00 Cr | Open |
| 02 Apr 2025 | Others | ₹12.50 Cr | Satisfied |
| 04 Jul 2018 | Others | ₹0.99 M | Satisfied |
| 13 Feb 2015 | Dbs Bank Ltd. | ₹5.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Cooper Pharma has a workforce of 122 employees as of Mar 29, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Cooper Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cooper Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge registered on 02 Apr 2025 via Charge ID 101073359 with Others was fully satisfied on 15 Sep 2025. was completed.
A charge with Others amounted to Rs. 12.50 Cr with Charge ID 101073359 was registered on 02 Apr 2025. was recorded as a recent event.
The activity A charge registered on 04 Jul 2018 via Charge ID 100232370 with Others was fully satisfied on 11 Mar 2025. was completed.
Cooper Pharma Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity Dinesh Kumar was appointed as a Director was appointed as a Director on 05 Jun 2024 & has been associated with this company since 1 year 5 months . was completed.
Progress on Cooper Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was documented.
No. 1 pharmaceutical company in Morocco in the field of digestive health .
The CIN of Cooper Pharma Limited is U24231DL1989PLC034902.
Cooper Pharma Limited is headquartered at Plot No. - 5, Nidhi Plaza - Ii, 2Nd Floor,, L.S.C. Gulabi Bagh, Delhi, Delhi, 110052.
Cooper Pharma Limited was incorporated on 02 February 1989.
The current directors of Cooper Pharma Limited are
The primary industry of Cooper Pharma Limited is Manufacturing.
Cooper Pharma Limited is unlisted.
The authorized capital of Cooper Pharma Limited is ₹3.00 Cr, and the paid-up capital is ₹1.00 Cr.
The compliance status of Cooper Pharma Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX